Literature DB >> 9333377

[High percentage of isolated anti-HBc-positive persons among prisoners].

S Neifer1, B Molz, U Sucker, E Kreuzpaintner, K Weinberger, W Jilg.   

Abstract

PURPOSE: Is the result "isolated Anti-HBc" higher among prisoners than in the normal population and can testing for HBV-DNA clarify the results? PATIENTS AND METHODS: In Berlin, 519 prisoners were serologically tested in 1994 for hepatitis-B and -C because of intravenous drug abuse and alcohol disease or signs of hepatitis. Beside virus antigen and antibodies, HBV-DNA was also measured by hybridisation technique or PCR.
RESULTS: 50.3% of all individuals showed markers of hepatitis-B and 36.8% of hepatitis-C. 19.2% of persons with hepatitis B markers were positive for anti HBc only, i.e. more than twice as many than in the normal population. 90% of the isolated anti-HBc-positive Persons were also anti-HCV positive, which is nearly double the number of individuals with other patterns of HBV markers. Half of them were tested for HBV-DNA. Whereas the hybridisation technique failed to detect HBV-DNA, 36% of sera were found positive by HBV-PCR.
CONCLUSION: This study shows again that the result "anti-HBc alone" is relatively frequent especially among prisoners. This pattern often seems associated with concurrent HCV-infection and in one third of the cases correlated with a chronic hepatitis-B. The result of an isolated anti-HBc should therefore always lead to further testing of anti-HCV and HBV-DNA by PCR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9333377

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  2 in total

1.  Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998.

Authors:  W Thierfelder; W Hellenbrand; H Meisel; E Schreier; R Dortschy
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients.

Authors:  Caroline Schmidbauer; David Chromy; Victor U Schmidbauer; Michael Schwarz; Mathias Jachs; David J M Bauer; Teresa Binter; Michael Apata; Dung T Nguyen; Mattias Mandorfer; Benedikt Simbrunner; Armin Rieger; Florian Mayer; Monika Breuer; Robert Strassl; Ralf Schmidt; Heidemarie Holzmann; Michael Trauner; Michael Gschwantler; Thomas Reiberger
Journal:  Liver Int       Date:  2021-08-05       Impact factor: 8.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.